Choreo LLC decreased its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS – Free Report) by 15.3% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 2,877 shares of the company’s stock after selling 518 shares during the period. Choreo LLC’s holdings in Addus HomeCare were worth $363,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ADUS. Wasatch Advisors LP grew its holdings in Addus HomeCare by 11.8% in the 3rd quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock valued at $138,782,000 after buying an additional 110,010 shares during the last quarter. Principal Financial Group Inc. lifted its position in shares of Addus HomeCare by 17.5% in the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock worth $67,293,000 after acquiring an additional 75,409 shares during the period. Harbor Capital Advisors Inc. lifted its position in shares of Addus HomeCare by 127.7% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 64,311 shares of the company’s stock worth $8,555,000 after buying an additional 36,071 shares during the period. Barclays PLC lifted its position in shares of Addus HomeCare by 204.8% during the 3rd quarter. Barclays PLC now owns 43,470 shares of the company’s stock worth $5,783,000 after buying an additional 29,207 shares during the period. Finally, Geode Capital Management LLC lifted its position in shares of Addus HomeCare by 7.1% during the 3rd quarter. Geode Capital Management LLC now owns 423,934 shares of the company’s stock worth $56,406,000 after buying an additional 28,284 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.
Analysts Set New Price Targets
ADUS has been the subject of several research analyst reports. StockNews.com upgraded Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Friday, January 24th. Macquarie reissued an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research note on Monday, November 4th. Royal Bank of Canada reissued an “outperform” rating and issued a $136.00 target price on shares of Addus HomeCare in a research note on Thursday, November 14th. JMP Securities initiated coverage on Addus HomeCare in a research note on Monday, December 16th. They set an “outperform” rating and a $150.00 price objective for the company. Finally, Citizens Jmp raised Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. One analyst has rated the stock with a sell rating, eight have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $134.22.
Insider Activity
In other news, CEO R Dirk Allison sold 25,000 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the transaction, the chief executive officer now owns 79,397 shares of the company’s stock, valued at approximately $9,905,569.72. This represents a 23.95 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Roberton James Stevenson sold 2,250 shares of the company’s stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the transaction, the executive vice president now directly owns 10,217 shares in the company, valued at $1,236,257. The trade was a 18.05 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 39,750 shares of company stock valued at $4,930,750. 4.60% of the stock is owned by insiders.
Addus HomeCare Trading Down 0.4 %
Addus HomeCare stock opened at $114.26 on Thursday. Addus HomeCare Co. has a 12 month low of $85.94 and a 12 month high of $136.72. The stock’s 50 day moving average is $126.29 and its 200-day moving average is $127.19. The company has a market capitalization of $2.07 billion, a price-to-earnings ratio of 26.15, a PEG ratio of 1.55 and a beta of 1.00.
Addus HomeCare Company Profile
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Stories
- Five stocks we like better than Addus HomeCare
- 3 Warren Buffett Stocks to Buy Now
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Inflation Persists, But So Do Stock Opportunities: Rally On
- What is a support level?
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.